Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Response Genetics's operating assets for the quarter that ended in Dec. 2015 was $29.43 Mil. Response Genetics's operating liabilities for the quarter that ended in Dec. 2015 was $9.49 Mil. Response Genetics's Total Assets for the quarter that ended in Mar. 2015 was $10.78 Mil. Therefore, Response Genetics's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2015 was 1.85.
Response Genetics Scaled Net Operating Assets Related Terms
Response Genetics Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Response Genetics's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Response Genetics Scaled Net Operating Assets Chart
RGDXQ vs PSID, GBSN, ETAH: Scaled Net Operating Assets Comparison
For the Diagnostics & Research subindustry, Response Genetics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Response Genetics Scaled Net Operating Assets vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Response Genetics's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Response Genetics's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 1.85 mean?
Response Genetics (RGDXQ) has a Scaled Net Operating Assets of 1.85 as of Dec. 2015. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Response Genetics and its competitors.
Is Response Genetics' Scaled Net Operating Assets too high?
Response Genetics' current Scaled Net Operating Assets is 1.85.
How does Response Genetics' Scaled Net Operating Assets compare to PSID and GBSN?
Response Genetics' Scaled Net Operating Assets of 1.85 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?
A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Response Genetics and its competitors. Response Genetics's current Scaled Net Operating Assets is 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Response Genetics stock overvalued right now?
Response Genetics (RGDXQ) has a current Scaled Net Operating Assets of 1.85. The current Scaled Net Operating Assets is 1.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Response Genetics (RGDXQ), the current Scaled Net Operating Assets is 1.85 as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Response Genetics Inc develops and sells diagnostic tests. It provides molecular- and biomarker-based tests and services which enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. The group generates revenue from providing Biopharma Services, Clinical Services, and Discovery Services, of which majority of the revenue is derived from providing Biopharma Services. Biopharma services provide companies with customized solutions for patient stratification and treatment selection through molecular- and biomarker-based testing services, customized assay development and trial design consultation. The firm operates in the US and internationally and generates prime revenue from the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGDXQ has been successfully added to your 